STOCK TITAN

ESSA Pharma to Present at Upcoming September Investor Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

ESSA Pharma Inc. (NASDAQ: EPIX), a clinical-stage pharmaceutical company dedicated to prostate cancer treatments, announces that CEO David R. Parkinson will present at two upcoming virtual investor conferences. Key details include the H.C. Wainwright Annual Global Investment Conference on September 13, 2021, and the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 21, 2021. Investors can access webcasts on ESSA's website, with archives available for 90 days post-event.

Positive
  • None.
Negative
  • None.

VANCOUVER, Canada and HOUSTON, Texas, Aug. 31, 2021 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that David R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will be presenting and hosting one-on-one meetings with investors at two upcoming virtual investor conferences. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be available for one-on-one meetings.

Presentation Details

Event: H.C. Wainwright Annual Global Investment Conference
Date: Monday, September 13, 2021
Time (on-demand): 7:00 a.m. ET

Event: Oppenheimer Fall Healthcare Life Sciences & MedTech Summit
Date: Tuesday, September 21, 2021
Time: 9:05 a.m. ET

Webcasts of the events can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the events, the webcasts will be archived on the ESSA website for 90 days.

About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.

Cision View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-upcoming-september-investor-conferences-301366567.html

SOURCE ESSA Pharma Inc

FAQ

When will ESSA Pharma present at the H.C. Wainwright Conference?

ESSA Pharma will present at the H.C. Wainwright Annual Global Investment Conference on September 13, 2021.

What is the date of the Oppenheimer Fall Healthcare Summit for ESSA Pharma?

The Oppenheimer Fall Healthcare Life Sciences & MedTech Summit will take place on September 21, 2021.

Who are the key executives presenting for ESSA Pharma at the conferences?

David R. Parkinson (CEO), Peter Virsik (COO), and David S. Wood (CFO) will represent ESSA Pharma.

How can I access the webcasts of ESSA Pharma's presentations?

Webcasts can be accessed in the Investors/Events & Presentations section of ESSA Pharma's website.

How long will the ESSA Pharma conference webcasts be available for?

The webcasts will be archived on ESSA's website for 90 days after the events.

ESSA Pharma Inc.

NASDAQ:EPIX

EPIX Rankings

EPIX Latest News

EPIX Stock Data

77.01M
43.38M
2.26%
81.19%
2.59%
Biotechnology
Pharmaceutical Preparations
Link
United States of America
VANCOUVER